Acadia Healthcare Company, Inc. $ACHC Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 4.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 45,813 shares of the company’s stock after selling 1,992 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Acadia Healthcare were worth $1,039,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the stock. Citigroup Inc. raised its position in shares of Acadia Healthcare by 5,144.2% during the first quarter. Citigroup Inc. now owns 2,376,209 shares of the company’s stock worth $72,047,000 after purchasing an additional 2,330,898 shares during the period. Hawk Ridge Capital Management LP raised its holdings in Acadia Healthcare by 437.5% during the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company’s stock worth $74,988,000 after buying an additional 2,013,126 shares during the period. Abrams Bison Investments LLC purchased a new stake in Acadia Healthcare during the first quarter valued at about $55,182,000. Maverick Capital Ltd. boosted its holdings in shares of Acadia Healthcare by 116.3% in the first quarter. Maverick Capital Ltd. now owns 2,246,923 shares of the company’s stock worth $68,127,000 after buying an additional 1,208,296 shares during the period. Finally, Brown Advisory Inc. purchased a new position in shares of Acadia Healthcare in the first quarter worth approximately $25,125,000.

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $22.95 on Tuesday. The company’s fifty day moving average is $23.47 and its two-hundred day moving average is $22.98. Acadia Healthcare Company, Inc. has a 52-week low of $17.13 and a 52-week high of $52.39. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The firm has a market capitalization of $2.12 billion, a price-to-earnings ratio of 15.20, a P/E/G ratio of 4.63 and a beta of 0.90.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business had revenue of $869.23 million during the quarter, compared to analysts’ expectations of $839.59 million. During the same quarter last year, the company earned $0.91 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on ACHC shares. Bank of America downgraded shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and reduced their price target for the company from $27.00 to $25.00 in a research report on Wednesday, September 10th. Guggenheim decreased their target price on Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Wednesday, October 8th. UBS Group lowered their target price on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating on the stock in a research note on Thursday, August 7th. Finally, Royal Bank Of Canada reduced their price objective on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.09.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.